n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Ischemia in 5 studies
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haruta, Y | 1 |
| Kobayakawa, K | 1 |
| Saiwai, H | 1 |
| Hata, K | 1 |
| Tamaru, T | 1 |
| Iura, H | 1 |
| Ono, G | 1 |
| Kitade, K | 1 |
| Kijima, K | 1 |
| Iida, K | 1 |
| Kawaguchi, K | 1 |
| Matsumoto, Y | 1 |
| Kubota, K | 1 |
| Maeda, T | 1 |
| Konno, DJ | 1 |
| Okada, S | 1 |
| Nakashima, Y | 1 |
| Wang, WM | 1 |
| Liu, Z | 1 |
| Liu, AJ | 1 |
| Wang, YX | 1 |
| Wang, HG | 1 |
| An, D | 1 |
| Heng, B | 1 |
| Xie, LH | 1 |
| Duan, JL | 1 |
| Liu, YQ | 1 |
| Medvedeva, YV | 1 |
| Lin, B | 1 |
| Shuttleworth, CW | 1 |
| Weiss, JH | 1 |
| Hochhauser, E | 1 |
| Ben-Ari, Z | 1 |
| Pappo, O | 1 |
| Chepurko, Y | 1 |
| Vidne, BA | 1 |
| Choi, JS | 1 |
| Kim, KA | 1 |
| Yoon, YJ | 1 |
| Fujikado, T | 1 |
| Joo, CK | 1 |
5 other studies available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Ischemia
| Article | Year |
|---|---|
Zinc chelator treatment in crush syndrome model mice attenuates ischemia-reperfusion-induced muscle injury due to suppressing of neutrophil infiltration.
Topics: Animals; Anti-Inflammatory Agents; Chelating Agents; Chemokines; Crush Syndrome; Cytokines; Ethylene | 2022 |
The Zinc Ion Chelating Agent TPEN Attenuates Neuronal Death/apoptosis Caused by Hypoxia/ischemia Via Mediating the Pathophysiological Cascade Including Excitotoxicity, Oxidative Stress, and Inflammation.
Topics: Animals; Apoptosis; Brain; Brain Ischemia; Cell Hypoxia; Chelating Agents; Disease Models, Animal; E | 2015 |
Intracellular Zn2+ accumulation contributes to synaptic failure, mitochondrial depolarization, and cell death in an acute slice oxygen-glucose deprivation model of ischemia.
Topics: Animals; Calcium; Cell Death; Chelating Agents; Disease Models, Animal; Ethylenediamines; Excitatory | 2009 |
TPEN attenuates hepatic apoptotic ischemia/ reperfusion injury and remote early cardiac dysfunction.
Topics: Animals; Apoptosis; Caspases; Chelating Agents; Ethylenediamines; Ischemia; Liver; Male; Rats; Rats, | 2005 |
Inhibition of cyclooxygenase-2 expression by zinc-chelator in retinal ischemia.
Topics: Animals; Chelating Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edetic Acid; Ethylenediami | 2006 |